| A high-resolution anatomical atlas of the transcriptome in the mouse embryo G Diez-Roux, S Banfi, M Sultan, L Geffers, S Anand, D Rozado, A Magen, ... PLoS biology 9 (1), e1000582, 2011 | 680 | 2011 |
| MicroRNA target prediction by expression analysis of host genes VA Gennarino, M Sardiello, R Avellino, N Meola, V Maselli, S Anand, ... Genome research 19 (3), 481-490, 2009 | 223 | 2009 |
| Dynamic regulation of the transcription initiation landscape at single nucleotide resolution during vertebrate embryogenesis C Nepal, Y Hadzhiev, C Previty, V Haberle, N Li, H Takahashi, AM Suzuki, ... Genome Research, 2013 | 137 | 2013 |
| Next Generation Sequencing of Pooled Samples: Guideline for Variants’ Filtering S Anand, E Mangano, N Barizzone, R Bordoni, M Sorosina, F Clarelli, ... Scientific Reports 6, 33735, 2016 | 114 | 2016 |
| SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors E Milan, C Lazzari, S Anand, I Floriani, V Torri, C Sorlini, V Gregorc, ... Journal of proteomics 76, 91-101, 2012 | 79 | 2012 |
| Global environmental issues SV Anand Open Access Scientific Reports 2 (2), 1-9, 2013 | 72 | 2013 |
| Neoadjuvant therapy in resectable pancreatic cancer: a critical review C Belli, S Cereda, S Anand, M Reni Cancer treatment reviews 39 (5), 518-524, 2013 | 51 | 2013 |
| The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases S Mishra, C Bernal, M Silvano, S Anand, A Ruiz i Altaba Oncogene 38 (29), 5817-5837, 2019 | 47 | 2019 |
| Progresses Toward Precision Medicine in RET-altered Solid Tumors C Belli, S Anand, JF Gainor, F Penault-Llorca, V Subbiah, A Drilon, ... Clinical Cancer Research 26 (23), 6102-6111, 2020 | 46 | 2020 |
| High throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites L Vanzan, H Soldati, V Ythier, S Anand, SMG Braun, N Francis, R Murr Nature Communications 12 (1), 3337, 2021 | 40 | 2021 |
| Development and validation of a serum metabolomic signature for endometrial cancer screening in postmenopausal women J Troisi, A Raffone, A Travaglino, G Belli, C Belli, S Anand, L Giugliano, ... JAMA Network Open 3 (9), e2018327-e2018327, 2020 | 32 | 2020 |
| The emerging role of PI3K inhibitors for solid tumour treatment and beyond C Belli, M Repetto, S Anand, C Porta, V Subbiah, G Curigliano British journal of cancer 128 (12), 2150-2162, 2023 | 31 | 2023 |
| Heterogeneous CD3 expression levels in differing T cell subsets correlate with the In vivo Anti-CD3–mediated T cell modulation A Valle, G Barbagiovanni, T Jofra, A Stabilini, L Perol, A Baeyens, ... The Journal of Immunology 194 (5), 2117-2127, 2015 | 30 | 2015 |
| Fabry disease: perspectives of urinary proteomics. M Cuccurullo, A Beneduci, S Anand, R Mignani, B Cianciaruso, A Bachi, ... Journal of Nephrology 23, S199-212, 2010 | 15 | 2010 |
| Direct ChIP-Seq significance analysis improves target prediction M Bansal, G Mendiratta, S Anand, R Kushwaha, RH Kim, M Kustagi, ... BMC genomics 16, 1-10, 2015 | 12 | 2015 |
| Next generation sequencing of pooled samples: guideline for variants’ filtering. Sci Rep 6: 33735 S Anand, E Mangano, N Barizzone, R Bordoni, M Sorosina, F Clarelli, ... | 11 | 2016 |
| Functional pro-metastatic heterogeneity revealed by spiked-scRNAseq is shaped by cancer cell interactions and restricted by VSIG1 C Bernal, M Silvano, Y Tapponnier, S Anand, C Angulo, AR i Altaba Cell reports 33 (6), 2020 | 9 | 2020 |
| Malignant Mesothelioma C Belli, S Anand BoD–Books on Demand, 2012 | 9 | 2012 |
| Translational therapies for malignant pleural mesothelioma C Belli, S Anand, G Tassi, D Fennell, L Mutti Expert review of respiratory medicine 4 (2), 249-260, 2010 | 7 | 2010 |
| The PCOS–NAFLD Multidisease Phenotype Occurred in Medaka Fish Four Generations after the Removal of Bisphenol A Exposure S Chakraborty, S Anand, S Coe, B Reh, RK Bhandari Environmental Science & Technology 57 (34), 12602-12619, 2023 | 6 | 2023 |
